Impact of Wearing a Support Garment Following Parietal Gastrectomy

Sponsor
Laval University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04938310
Collaborator
Bodynov (Other), Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval (Other)
60
2
36

Study Details

Study Description

Brief Summary

Custom-made orthopedic support equipment and abdominal-lumbar support belts offer promising potential for several aspects affecting the health and well-being of people with obesity who choose a surgical weight loss option. However, research is needed to quantitatively document their short and long term effects on a wide range of parameters related to mobility, quality of life, lower back pain and skin maceration following parietal gastrectomy. The objective of this study is to characterize the effect of a support garment in an experimental design where a subgroup of participants will be randomized and followed for the first 12 months after a gastrectomy. The measures will be: physical activity, lower back pain, self-esteem, quality of life, skin maceration and infections. This study will scientifically document the usefulness and effectiveness of support garments throughout the weight loss surgery process.

Condition or Disease Intervention/Treatment Phase
  • Procedure: sleeve gastrectomy
  • Device: support garment
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Impact of Wearing a Support Garment on Mobility, Functional Capacity, Self-esteem, Quality of Life and Skin Maceration Following Parietal Gastrectomy
Anticipated Study Start Date :
Jun 1, 2021
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Jun 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control Group

Sleeve gastrectomy

Procedure: sleeve gastrectomy
sleeve gastrectomy

Experimental: Support garment group

Sleeve gastrectomy followed by a period of 12-month with a support garment

Procedure: sleeve gastrectomy
sleeve gastrectomy

Device: support garment
A custom made support garment

Outcome Measures

Primary Outcome Measures

  1. Excess skin [From baseline to 12 month following sleeve gastrectomy]

    Excess skin measured with the Iglesias scale, scores are from 1 to 5, higher score means a worse excess skin

  2. Skin maceration [From baseline to 12 month following sleeve gastrectomy]

    maceration evaluated with an in-house questionnaire reported as presence or absence of skin maceration

  3. Skin infection [From baseline to 12 month following sleeve gastrectomy]

    infection evaluated with an in-house questionnaire reported as presence or absence of skin infection

  4. Impact of excess skin [From baseline to 12 month following sleeve gastrectomy]

    Sahlgrenska Excess Skin questionnaire assesses excess skin after weight loss for specific body parts and body as a hole. Inconvenience of excess skin is evaluated on a scale from 0 to 10, higher score means higher perception that the excess skin is an inconvenience.

  5. Physical activity [From baseline to 12 month following sleeve gastrectomy]

    Physical activity evaluated by wearing an activity monitor

  6. Physical activity [From baseline to 12 month following sleeve gastrectomy]

    Global Physical Activity Questionnaire

  7. Lower back pain [From baseline to 12 month following sleeve gastrectomy]

    Quebec back pain scale, scores are from 0 to 100, higher score means greater difficulty in carrying out activities due to low back pain

  8. Self esteem [From baseline to 12 month following sleeve gastrectomy]

    Rosenberg self esteem scale, scores are from 10 to 40, higher score mean a stronger self esteem

  9. Self esteem related to physical appearance [From baseline to 12 month following sleeve gastrectomy]

    Body Esteem Scale for Adolescent and Adults contains 3 subscales for weight, appearance and attribution. Scores are from 1 to 5, higher score means higher self esteem.

  10. Body image [From baseline to 12 month following sleeve gastrectomy]

    Gender-specific body-size guide is a pictorial method of assessing the perception of weight status. It consists of 10 standardized images of adults with known BMI values and is a validated body size perception tool. The scale is gender specific and images range from underweight (BMI <18.5) to class III obesity (BMI> = 40) with approximately a 3 point difference in BMI between the figures on the scale.

  11. Body image [From baseline to 12 month following sleeve gastrectomy]

    body shape questionnaire, scores are from 34 to 204, higher score means worse feeling about the appearance.

  12. Body image [From baseline to 12 month following sleeve gastrectomy]

    Eating Disorders Examination Questionnaire contains subscales for restraint, eating concern, shape concern and weight concern. Each subscales and global scale scores are form 0 to 6, higher score means worse outcome

  13. Severity of depression symptoms [From baseline to 12 month following sleeve gastrectomy]

    Beck Depression Inventory II questionnaire, scores are from 0 to 63, higher score means more severe depressive symptoms.

  14. Anxiety [From baseline to 12 month following sleeve gastrectomy]

    State-Trait Anxiety Inventory contains 2 subscales for usual emotional state and current emotional state. Scores are from 20 to 80, higher scores means higher anxiety state.

  15. Social Physique Anxiety [From baseline to 12 month following sleeve gastrectomy]

    Social Physique Anxiety Scale, scores are from 12 to 60, higher score means more anxiety

  16. Quality of life [From baseline to 12 month following sleeve gastrectomy]

    Laval questionnaire contains 6 subscales for symptoms, activity/mobility, personal hygiene/clothing, emotions, social interactions, and sex life. scores are from 1 to 7, higher score means higher quality of life in each domain

  17. marital satisfaction [From baseline to 12 month following sleeve gastrectomy]

    Dyadic adjustment scale, scores are from 0 to 151, higher score indicates a higher level of marital functioning

  18. social ideals of physical appearance [From baseline to 12 month following sleeve gastrectomy]

    Sociocultural Attitude Towards Appearance Questionnaire-4 contains 6 subscales (internalization: thinness / low fat mass, internalization: muscular, internalization: general attractiveness, pressures: family, pressures: media, pressures: similar and other significant). Scores are from 1 to 5, higher scores indicating greater internalization and endorsement of societal appearance ideals

  19. gastroesophageal reflux disease [From baseline to 12 month following sleeve gastrectomy]

    GastroEsophageal Reflux Disease Score, scores are from 0 to 96, higher score indicates worse gastroesophageal reflux symptoms

  20. adherence in wearing the support garment [From baseline to 12 month following sleeve gastrectomy]

    adherence in wearing the support garment evaluated with an adherence journal. Adherence will be calculated as a percentage from the total number of days the participant wears the garment out of the total for the intervention.

  21. persistence in wearing the support garment [From baseline to 12 month following sleeve gastrectomy]

    persistence in wearing the support garment will be calculated as a percentage by reporting the number of participants who have stopped wearing the garment compared to those who have used it.

  22. Body composition [From baseline to 12 month following sleeve gastrectomy]

    body fat composition assessed by impedance

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • meeting the NIH criteria for bariatric surgery

  • BMI >= 35 kg/m2

Exclusion Criteria:
  • chronic pulmonary obstructive disease

  • gastric stoma

  • psychiatric disease contraindicated for bariatric surgery

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Laval University
  • Bodynov
  • Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Laurent Biertho, Principal Investigator, Laval University
ClinicalTrials.gov Identifier:
NCT04938310
Other Study ID Numbers:
  • Bodynov
First Posted:
Jun 24, 2021
Last Update Posted:
Jun 24, 2021
Last Verified:
Jun 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Laurent Biertho, Principal Investigator, Laval University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 24, 2021